M&A prospects in the healthcare industry

By Sean Williamson (Toronto) on September 27, 2016 Posted in M&A, Pharmaceuticals and life sciences

RR Donnelley’s August 2016 VENUE Market Spotlight focused on the healthcare industry and the prospects for M&A activity in that space over the next 12 months. The report notes that there were 678 healthcare transactions in the first half of 2016 with an aggregate value of US$171.3 billion globally. These figures represent declines of 5% and … Continue reading

2016 outlook for spinoff, carve out and asset sale activities

By Troy Ungerman (Toronto) on February 24, 2016 Posted in Corporate finance

Of the many ways a corporation can divest its assets or shares to create value, asset sales, equity carve outs and spinoffs are some of the most common methods. In an asset sale, a business sells its assets in exchange for cash proceeds or other forms of consideration. An equity carve out is where a … Continue reading

Future of private equity leveraged buyout financing optimistic

By Troy Ungerman (Toronto) on May 12, 2015 Posted in Corporate finance, Technology and innovation

Recently, RR Donnelley sought the assistance of Mergermarket Group to interview professionals in the US, Europe, and Asia-Pacific about leveraged buyout financing. Mergermarket Group published its survey results on the environment of leveraged buyout financing in its April 2015 edition of the Venue Market Spotlight. Availability of buyout financing A majority of survey respondents indicates … Continue reading